Search results :

Lamivudine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AF05

Side effects

Options: Show MedDRA Preferred Terms,   display all 23 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Headache common, 5% - 42% 1% - 37% x x x x x x x x x x x x x x x x x
Fatigue common, 1% - 26% 3.12% - 28% x x x x x x x x x x x x x x x x x
Malaise common, 3.66% - 26% 3% - 28% x x x x x x x x x x x x x x x x x
Respiratory tract infection 18.1% - 20.5% 17% x x x x x x x x x x x x x
Gastrointestinal pain 17% - 20% 15% - 19% x
Cough 9.72% - 18% x x x x x x x x x x x
Throat sore 13% 8% x x x
Diarrhoea common, 2.62% - 22% 2.08% - 18% x x x x x x x x x x x x x x x x x x x
Body temperature increased common, 6% - 32% 4% - 12% x x x x x x x x x x x x
Nausea common, 2% - 46% 3.12% - 18% x x x x x x x x x x x x x x x x x
Stomatitis postmarketing, 6% - 12% x x x x x x x x x x x
Chills 12% x x x x x x x
Abdominal pain 11% x x x x x x x x
Hepatomegaly 10.6% - 11% x x x x x x x x x x x x x x x x x x
Lymphadenopathy postmarketing, 9% - 11.4% x x x x x x x x x x x x
Rhinorrhoea 8% - 11% x x x x x x
Infection 6.9% - 25% 21% x x x x x x
Discomfort 8.33% - 14% x x x x x x x
Abdominal discomfort 4.19% - 17.4% 8.33% - 17% x x x x x x x x x x x
Musculoskeletal pain 7.74% - 22.1% x x x x x x x x x
Neuropathy 8.5% - 23.3% x x x x x x x x
Pain 2% - 22.1% 8.33% - 17% x x x x x x x x x x x x x
Wheezing postmarketing, 7% - 9% x x x x x x x x x x
Creatine phosphokinase increased 9% 5% x x
Breath sounds abnormal postmarketing, 7% - 9% x x x x x x x x x x
Sleep disorder 4% - 11.6% x x x x x x
Splenomegaly postmarketing, 7.63% - 8% x x x x x x x x x x x
Vomiting common, 3.14% - 16% 3% - 17% x x x x x x x x x x x x x x x x x
Viral infection 4.3% - 20.9% x x x x
Anorexia 7% - 11% 8% x x x x x x x x
Sweating 1% - 7.6% x x x x
Decreased appetite 7% x x x x x
Other sleep disturbances 7% x x x x x
Insomnia 7% x x x x x x x
Gastrointestinal infection 5.2% - 14% x x x
Sinusitis 4.7% - 7.2% x x x
Rash postmarketing — 1% - 14% 2.08% x x x x x x x x x x x x x x x x x x
Myalgia common, 2% - 11.6% x x x x x x x x x x x x x x
Fungal skin infection 4.1% - 7% x x x
Gastrointestinal discomfort 4.1% - 7.2% x x x x
Folliculitis 3.5% - 11.6% x x x x
Acne 3.5% - 11.6% x x x x
Bronchitis 4.7% - 10% x x x x
Arthralgia common, 5% x x x x x x x x x x x x
Dyspepsia 2% - 5% 4% x x x x x x
Cramp muscle postmarketing, common x x x x x x x x
Myopathy common x x x x x x x x x x x x x
Abdominal pain upper common x x x x
Sweating increased 5% 4% x
Hyperlactacidaemia common x x x x x x x
Viral skin infection 3.5% - 7% x x x
Depressive disorder 4% x x x x x x x x x
Dizziness 3.9% - 10.4% x x x x x x x x x x x x
Gas 4% x
Liver function test abnormal 3.66% 4.17% x x x x
Inflammation 1.7% - 5.2% x x x
Respiration abnormal 2% - 5.6% x x x x
Abdominal cramps 3% x x x x x
Abdominal distension 3% x
Neutropenia uncommon, 3% - 8% x x x x x x x x x x
Pharyngitis 2.09% 4.17% x x
Dry mouth 2% x
Mouth ulceration 1% x x
Affective disorder 1% x x x
Lactic acidosis postmarketing, rare x x x x x x x x x x x x x x x x x x x
Alopecia postmarketing, common x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x
Anaemia postmarketing — 1% - 4% x x x x x x x x x x x x x x x
Angioedema rare x x x
Asthenia postmarketing, 8% - 19% 2% - 18% x x x x x x x x x x
Hepatitis postmarketing x x x x x x x
Hepatitis B postmarketing x x
Hyperglycaemia postmarketing x x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x
Pancreatitis postmarketing, rare x x x x x
Paraesthesia very rare, postmarketing x x x x x x x x x x x x x x x x x x x x
Neuropathy peripheral postmarketing x x x x x x x x x x x x x x x x x x
Pruritus postmarketing — 1% x x x x x x x x x x x x x x
Aplasia pure red cell very rare, postmarketing x x x x x x x x x x x x x x x
Rhabdomyolysis very rare — rare x x x x x x x x x x x x x x x x x x x
Thrombocytopenia very rare — 1% - 3% x x x x x x x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x
Muscular weakness postmarketing x x x x
Blood and lymphatic system disorders postmarketing x x x x
Hepatic steatosis postmarketing x x x x x x x x x x
Acidosis x x x
Agranulocytosis x
Amblyopia x
Aplastic anaemia x
Anxiety x x x x
Autoimmune disorder x
Back pain x
Bone disorder x x
Chest pain x
Confusional state x x
Connective tissue disorder x x x x x x x
Constipation x
Dysphagia x
Dehydration x x x
Dysgeusia x
Dyspnoea x
Dysuria x
Oedema x
Epistaxis x
Eructation x
Erythema multiforme x
Flatulence x
Gastroenteritis x x x
Gastrointestinal disorder x x x x
Gingival bleeding x
Basedow's disease x
Gynaecomastia x
Blood disorder x x x x
Chronic hepatitis x x x x
Hepatitis C x x x
Hoarseness x
Hyperpathia x
Hypercholesterolaemia x
Hypertriglyceridaemia x x x x
Hypertrophy of breast x
Hypoaesthesia x
Hypoglycaemia x x x
Hypotension x
Immune system disorder x x
Influenza x
Insulin resistance x
Jaundice x x x
Leukopenia x
Lipodystrophy x
Mediastinal disorder x
Muscle atrophy x
Nervous system disorder x x x x
Nervousness x
Opportunistic infection x
Pancytopenia x
Phlebitis x
Polyuria x
Pregnancy x x x
Rhinitis x
Convulsion x x x x x
Skin infection x x x
Muscle spasms x
Stevens-Johnson syndrome x
Suicide x
Suicide attempt x
Syncope x
Taste disorders x x
Thirst x
Tremor x
Erythema x x x x x
Pollakiuria x
Vasculitis x
Vasodilation x
Vertigo x
Body odor x
Mood swings x
Photophobia x
Migraine x
Amylase increased x
Bone marrow depression x
Aspartate aminotransferase increased x x x
Alanine aminotransferase increased x x
Urinary hesitation x
Malnutrition x x x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x x
Sickness x
Hyperamylasaemia x x
Muscle twitching x
Oedema auricular x x x x x
Sepsis x x x
Rectal haemorrhage x
Hepatobiliary disease x x x x x x x x x
Buffalo hump x
Auricular swelling x x x x x
Drug interaction x
Hypoxemia x
Dyspeptic signs and symptoms x x
Pancreatic enzymes abnormal x x
Fat redistribution x
Raised liver function tests x x x x x x
Cardiomyopathy x x
Nail pigmentation x
Sensitisation x x
Hearing impaired x
Renal impairment x x x
Mucosal pigmentation x x
Somnolence x
Injury x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LAMIVUDINE

Side effects:25
Source:FDA Structured Product Label

LAMIVUDINE

Side effects:27
Source:FDA Structured Product Label

LAMIVUDINE

Side effects:28
Source:FDA Structured Product Label

lamivudine / lamivudine

Side effects:29
Source:EMA

lamivudine / lamivudine

Side effects:29
Source:EMA

Lamivudine / ZETLAM

Side effects:30
Source:medicines.org.au

Lamivudine / Epivir-HBV

Side effects:40
Source:FDA

LAMIVUDINE / HEPTOVIR

Side effects:41
Source:Health Canada

lamivudine / lamivudine

Side effects:45
Source:EMA

LAMIVUDINE

Side effects:55
Source:FDA Structured Product Label

LAMIVUDINE

Side effects:58
Source:FDA Structured Product Label

LAMIVUDINE

Side effects:62
Source:FDA Structured Product Label

LAMIVUDINE

Side effects:62
Source:FDA Structured Product Label

Lamivudine / LAMIVUDINE

Side effects:69
Source:medicines.org.au

LAMIVUDINE / 3TC

Side effects:74
Source:Health Canada

Lamivudine / 3TC TABLETS AND ORAL SOLUTION

Side effects:77
Source:medicines.org.au

Alphapharm / LAMIVUDINE + ZIDOVUDINE 300mg

Side effects:108
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label